The exit strategies of life sciences companies have become more varied due to the current situation being experienced by global capital markets. This is primarily the case for German life sciences companies as well. The choice of exit scenario must be made carefully based on the individual circumstances of the company. The panelists will present and discuss the different exit variations and commercialization strategies, specifically when considering exits of German life sciences companies in other countries (such as the United States or Switzerland)
Collaboration Deals
Joint Ventures
Staged Exits
Milestone Agreements
Indemnification vs. Warranties
Sub-licensing structures
Big pharma deal terms
Speakers:
Sven Riethmueller (Attorney, member of New York and Massachusetts Bars), Foley & Lardner LLP
Dr. Irina Staatz-Granzer, Staatz Business Development and Strategy
Professor Dr. Christof Hettich (Rechtsanwalt), Rittershaus
Related Insights
08 May 2025
Events
Operating in India: Tackling Entry Challenges and Country-Specific Legal and Cultural Dynamics to Strengthen and Monitor Compliance
Foley Partner David Simon spoke at ACI’s 20th Annual FCPA & Anti-Corruption for the Life Sciences Industry Conference in New York on May 8, 2025. He participated in a panel discussion focused on India, titled “Tackling Entry Challenges and Country-Specific Legal and Cultural Dynamics to Strengthen and Monitor Compliance.”
08 May 2025
Foley Viewpoints
Achieving DEI Compliance…On Your Website
Diversity, Equity & Inclusion (DEI) efforts, and the term itself, have become increasingly scrutinized and subjected to legal challenges by both government and private actors, making an understanding of the current DEI climate and applicable law critical to organizations advancing efforts to support DEI initiatives.
08 May 2025
Health Care Law Today
HIPAA Compliance for AI in Digital Health: What Privacy Officers Need to Know
Artificial intelligence is rapidly reshaping the digital health sector, driving advances in patient engagement, diagnostics, and operational efficiency.